Category: Coagulopathy

JC: Blood Products in Trauma – What’s the Best (I)TACTIC?

Bleeding trauma patients present a couple of challenges to us in the Emergency Department. Increasingly, our aging population continues to engage in energetic daily pursuits while increasing numbers are prescribed newer direct oral anticoagulant treatments

New NICE Guidelines on diagnosis and management of venous thromboembolism

In the midst of everything that is going on with COVID-19 it is easy to see how important non coronavirus stuff can get overlooked. But we still need to keep our eyes open. After a

JC: AVP in Haemorrhagic Shock. St Emlyn’s

Blood product transfusion can be lifesaving for patients who have suffered major trauma, but the associated side-effects and risks, mean that most people would agree that less is more. This paper by Sim et al

St Emlyn’s April 2018 blog and podcast round up.

Simon and Iain talk through what the team has been up to in April. All the blogs should be on the website and of course you can subscribe to the podcast via iTunes or via

CRYOSTAT-2 with Ross Davenport

You might be aware that an exciting new trial has started called Cryostat-2.  This is exciting as it has the potential to improve patient outcomes, but also because it will involve all the Major Trauma

JC: Does earlier TXA save lives? St.Emlyn’s

Administration of tranexamic acid (TXA) is integral part of the management for major trauma patients in the UK. It is deemed such an important aspect that its administration is used as a quality indicator to

St Emlyn’s in Review – October 2017

It’s great to be back podcasting again after what has been a busy few months, We’re sorry for the hiatus, but occasionally other stuff gets in the way! Here we review some of the amazing

JC: Reversal of DOACs with Andexanet Alfa. St.Emlyn’s

123We are in a new age of anticoagulation, Warfarin is becoming a drug of the past. To the benefit of our patients we are no longer dragging them into hospital once a week to check

JC: Getting the Balance Right: The PROPPR Trial

  Last week saw the publication of the results of the Pragmatic Randomised Optimal Platelet and Plasma Ratios (PROPPR) Trial by Holcomb et al. (et al. includes almost all of the big names in massive

Get the NOAC Knowhow: Novel Oral Anticoagulants Part 1

Where would we be without warfarin?  The good old rat poison has served us brilliantly for decades, allowing us to anticoagulate patients to treat and prevent venous thromboembolism, prevent stroke in AF, and so much


Translate »